Genetic studies have implicated microglia, the brain’s innate immune cells, as critical players in neurodegeneration. In response, the field has focused on transcriptionally defining the diverse microglial activation states that occur across models of neurodegeneration. Through these efforts, we have discovered several new microglial activation states that are altered in . . .